Physician

Pravin P Patel, MD

According to 2025 Medicare claims, Pravin Patel, MD (NPI: 1124098603) practices family practice in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from Tate, MS. This provider's primary affiliated billing organization is PRAVINCHANDRA P. PATEL, MD P.C. (NPI: 1457527475; TIN: 640925177) and primary practice location at 38618-3915.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 584 traditional Medicare patients, billed 20,527 HCPCS/CPT codes, and received $353,378 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,146 prescription claims across 1,156 beneficiaries totaling $1,487,466 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 589 claims. Open Payments data shows 140 records totaling $2,459. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $687,072 to $353,378. Similarly, Part D prescription costs have declined steadily, from $2,404,186 to $1,487,466. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	907	42,535	$687,072
2016	927	40,610	$644,719
2017	888	28,048	$528,536
2018	895	25,650	$554,830
2019	917	23,846	$602,344
2020	834	22,452	$579,304
2021	747	19,921	$609,547
2022	684	20,496	$594,049
2023	623	15,970	$411,590
2024	584	20,527	$353,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,158	46,095	$2,404,186
2016	1,154	47,759	$2,705,704
2017	1,150	45,517	$2,973,523
2018	1,234	44,628	$2,949,637
2019	1,289	40,848	$3,052,827
2020	1,203	21,981	$1,698,253
2021	1,161	19,292	$1,712,172
2022	1,166	15,847	$1,603,306
2023	1,153	13,112	$1,774,619
2024	1,156	11,146	$1,487,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	843	3,415	$217,326
2016	823	3,156	$175,712
2017	679	3,031	$111,604
2018	688	2,807	$108,228
2019	519	2,314	$76,815
2020	356	1,637	$63,422
2021	281	1,379	$83,778
2022	233	1,118	$72,856
2023	154	863	$100,921
2024	72	589	$83,950

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	521	1,759	$81
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	296	636	$12
96372	Injection of drug or substance under skin or into muscle	267	1,029	$9
36415	Insertion of needle into vein for collection of blood sample	395	830	$9
81000	Manual urinalysis test with examination using microscope, non-automated	334	633	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	140	5,439	$197,932
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	140	5,580	$116,688
Ozempic	Semaglutide	95	3,606	$104,300
Farxiga	Dapagliflozin Propanediol	60	4,307	$79,594
Linzess	Linaclotide	93	3,870	$66,520

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	44	$37,659
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	31	$16,650
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$11,698
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	17	124	$9,456
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	13	60	$1,449

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	140	$2,459	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pravin P. Patel, MD?

Tedicare shows public-source Medicare data for Pravin P. Patel, MD (NPI 1124098603), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pravin P. Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pravin P. Patel, MD?

Pravin P. Patel, MD is linked to PRAVINCHANDRA P. PATEL, MD P.C. (billing NPI 1457527475) in the available physician profile data.

Does Pravin P. Patel, MD have Open Payments data?

Pravin P. Patel, MD has 140 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.